Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joline S J Lim

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Respiratory Disease|August 3, 2016
Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidenceJoline S J Lim, Ross A Soo
Cancers|August 23, 2017
Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP InhibitorsJoline S J Lim, David S P Tan
Journal of Thoracic Disease|November 22, 2016
Emerging strategies for the treatment of advanced small cell lung cancerJoline S J Lim, Dearbhaile Collins, Timothy A Yap
British Journal of Cancer|February 6, 2023
Immune checkpoint inhibitor combinations-current and emerging strategiesRobert J Walsh, Raghav Sundar, Joline S J Lim
Current Problems in Cancer|April 19, 2017
Circulating tumor DNA-From bench to bedsideJoline S J Lim, Filip Janku, Timothy A Yap
Cancer Discovery|July 3, 2016
CDK4/6 Inhibitors: Promising Opportunities beyond Breast CancerJoline S J Lim, Nicholas C Turner, Timothy A Yap
Trends in Pharmacological Sciences|November 23, 2016
Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel TherapeuticsDearbhaile C Collins, Raghav Sundar, Joline S J Lim, et al.
Cancers|September 28, 2023
Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast CancerJoseph J Zhao, Khi Yung Fong, Yiong Huak Chan, et al.
Antioxidants & Redox Signaling|December 17, 2019
Targeting Cell Metabolism as Cancer TherapyNatalie Y L Ngoi, Jie Qing Eu, Jayshree Hirpara, et al.
British Journal of Cancer|February 16, 2023
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trialsJerold Loh, Jiaxuan Wu, Jenny Chieng, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Respiratory Disease|August 3, 2016
Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidenceJoline S J Lim, Ross A Soo
Cancers|August 23, 2017
Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP InhibitorsJoline S J Lim, David S P Tan
Journal of Thoracic Disease|November 22, 2016
Emerging strategies for the treatment of advanced small cell lung cancerJoline S J Lim, Dearbhaile Collins, Timothy A Yap
British Journal of Cancer|February 6, 2023
Immune checkpoint inhibitor combinations-current and emerging strategiesRobert J Walsh, Raghav Sundar, Joline S J Lim
Current Problems in Cancer|April 19, 2017
Circulating tumor DNA-From bench to bedsideJoline S J Lim, Filip Janku, Timothy A Yap
Cancer Discovery|July 3, 2016
CDK4/6 Inhibitors: Promising Opportunities beyond Breast CancerJoline S J Lim, Nicholas C Turner, Timothy A Yap
Trends in Pharmacological Sciences|November 23, 2016
Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel TherapeuticsDearbhaile C Collins, Raghav Sundar, Joline S J Lim, et al.
Cancers|September 28, 2023
Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast CancerJoseph J Zhao, Khi Yung Fong, Yiong Huak Chan, et al.
Antioxidants & Redox Signaling|December 17, 2019
Targeting Cell Metabolism as Cancer TherapyNatalie Y L Ngoi, Jie Qing Eu, Jayshree Hirpara, et al.
British Journal of Cancer|February 16, 2023
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trialsJerold Loh, Jiaxuan Wu, Jenny Chieng, et al.
Pageof 3